ABSTRACT
The HIV-1 envelope glycoprotein complex (Env) is incorporated into developing particles at the plasma membrane (PM). The cytoplasmic tail (CT) of Env is known to play an essential role in particle incorporation, but the exact mechanisms underlying this function of the CT remain uncertain. Upon reaching the PM, trafficking signals in the CT interact with host cell endocytic machinery, directing Env into endosomal compartments within the cell. Prior studies have suggested that Env must travel through the endosomal recycling compartment (ERC) in order for it to return to the PM site of particle assembly. Expression of a truncated form of the ERC-resident trafficking adaptor Rab11 family interacting protein 1C resulted in CT-dependent sequestration of Env in the condensed ERC, preventing recycling of Env to the PM. In this work, the motifs within the CT responsible for ERC localization of Env were systematically mapped. A small deletion encompassing the N-terminal portion of lentiviral lytic peptide 3 (LLP3) eliminated ERC localization. Site-directed mutagenesis identified two tryptophan-based motifs (WE790–791 and WW796–797) within the N-terminus of LLP3 that were essential for ERC localization of Env. Mutant viruses bearing substitutions in these motifs were deficient in Env incorporation, with a corresponding loss of particle infectivity and a significant defect in replication in a spreading infection assay. These results identify two tryptophan-based motifs at the N-terminal portion of LLP3 that mediate ERC localization and Env incorporation, providing additional supporting evidence for the importance of cellular recycling pathways in HIV-1 particle assembly.
IMPORTANCE
The HIV-1 envelope glycoprotein (Env) is an essential component of the virus and has an exceedingly long cytoplasmic tail (CT). Previous studies have suggested that trafficking signals in the CT interact with host factors to regulate the incorporation of Env into particles. One particular area of interest is termed lentiviral lytic peptide 3 (LLP3), as small deletions in this region have been shown to disrupt Env incorporation. In this study, we identify a small region within LLP3 that regulates how Env associates with cellular recycling compartments. Mutants that reduced or eliminated Env from the recycling compartment also reduced Env incorporation into particles. These findings emphasize the importance of two tryptophan motifs in LLP3 for the incorporation of Env into particles and provide additional support for the idea that the CT interacts with host recycling pathways to determine particle incorporation.
KEYWORDS: HIV envelope, endosomal recycling compartment, cytoplasmic tail, trafficking motifs, HIV assembly
INTRODUCTION
The envelope glycoprotein (Env) of HIV-1 is an essential viral protein that mediates binding to CD4 and coreceptor molecules, thereby triggering fusion and entry into target cells. Env is also the principal neutralizing determinant of the virus and has been the focus of active research in the HIV vaccine field. Env is synthesized in the rough endoplasmic reticulum as the precursor protein gp160, where it is co-translationally glycosylated and assembled into trimers (1, 2). Env is cleaved by furin-like proteases in the Golgi apparatus into the gp120 surface and gp41 transmembrane subunits, which remain noncovalently associated as the heterotrimer is transported to the plasma membrane (3, 4). Upon arrival at the plasma membrane, Env trimers are rapidly endocytosed via a clathrin- and AP-2-dependent mechanism that relies upon a membrane-proximal Yxxϕ motif in the Env cytoplasmic tail (CT) (5 – 9). The trafficking steps taken by Env following endocytosis that regulate its anterograde movement back to the plasma membrane (PM) for particle incorporation remain incompletely defined.
Host recycling pathways are likely to be required for directing Env to the site of particle assembly and promoting its incorporation into developing HIV-1 particles. Rab11 family interacting protein 1C (FIP1C) is a trafficking adaptor that has been implicated in the trafficking of Env from the endosomal recycling compartment (ERC) to the plasma membrane. Depletion of FIP1C led to a reduction of Env incorporation in T cell lines, and overexpression of a C-terminal fragment of FIP1C resulted in sequestration of Env within the ERC (10, 11). The small GTPase Rab14 interacts with FIP1C and contributes to Env recycling and particle incorporation (11, 12). An alternative pathway for endocytosed Env involves interaction with the retromer complex, resulting in retrograde trafficking of Env back to the Golgi and leading to a reduction of Env at the cell surface (13). A fraction of intracellular Env has also been observed to colocalize with markers of the lysosome (6, 14, 15). Inhibitors of lysosomal function result in reduced degradation of Env, making it likely that lysosomal degradation is the default fate of endocytosed Env in the absence of active anterograde trafficking (3, 15). Thus, multiple potential trafficking pathways are available for Env trafficking following endocytosis, with some routes leading to productive particle incorporation at the PM and others directing Env to alternative pathways, including degradation in the lysosome. Identification of specific trafficking motifs present in the CT that are responsible for recycling and subsequent particle incorporation is therefore of considerable interest and is the subject of this report.
The presence of a long CT is a characteristic feature of most lentiviral Env proteins. HIV-1 and simian immunodeficiency virus incorporate a CT of approximately 150 amino acids. The expression of a long CT suggests that this provides an added function or functions that are evolutionarily advantageous to the virus (16). The Env CT consists of an N-terminal unstructured region followed by three amphipathic alpha helices known as the lentiviral lytic peptides (LLPs), numbered from N- to C-terminus as LLP2/LLP3/LLP1 (17). These domains have been shown to contribute to a baseplate structure supported by a complex network of intratrimer bonds as well as bonds linking the LLPs to the transmembrane domain (18, 19). Specific motifs within the LLPs have previously been implicated in interactions with cellular trafficking machinery. Interactions with the retromer complex have been mapped to regions of the CT termed inhibitory sequences (IS1 and IS2), with IS1 in the unstructured region of the CT and IS2 overlapping LLP2 (13, 20). The N-terminal portion of LLP3 appears to have particular importance for Env incorporation into HIV-1 particles. Murakami and Freed showed that small deletions in this region result in Env incorporation defects and reduce viral replication (21). A systematic mutagenesis of tyrosine-based and dileucine motifs in the CT found that a nine-residue sequence at the N-terminus of LLP3 (Y795WWNLLQYW802) plays a critical role in HIV replication in T cells (22). Our group previously demonstrated that the YW795 motif is an important determinant of Env incorporation, as a YW795SL mutant virus was deficient in Env incorporation and replicated poorly in T cell lines (23). The Env incorporation defect introduced by mutation of the YW795 motif could be rescued by a downstream second-site reversion introducing a single amino acid change near the C-terminus of the CT (YW795SL/L850S), restoring Env incorporation and viral replication. Although a direct interaction of this motif with FIP1C has not been demonstrated, the YW795SL mutant virus was insensitive to FIP1C depletion, while Env incorporation by revertant YW795SL/L850S was reduced by FIP1C depletion. Other groups have examined the second YW motif in this region, YW802, showing that disruption of this motif reduces Env incorporation and fusogenicity (22, 24, 25).
An intriguing aspect of Env incorporation into particles is that the CT is required for particle incorporation in a cell type-dependent manner (26). Large truncations or deletions of the CT do not inhibit the incorporation of Env into particles budding from model epithelial cell lines, including 293T and COS cells, or from the MT-4 T cell line. Cell types that do not require an intact CT are termed permissive cells, indicating the permissive nature of the incorporation of Env bearing a truncated CT. In contrast, an intact CT is required for efficient particle incorporation and replication in many T cell lines, including Jurkat, CEM, and H9 (26 – 28). Furthermore, an intact CT is required for particle incorporation and replication in primary CD4+ T cells and macrophages (26). The precise mechanism by which the CT mediates HIV-1 Env incorporation remains incompletely understood. However, a growing body of evidence supports a role for intracellular trafficking mediated by the CT in directing Env incorporation into HIV-1 particles [reviewed in reference (29)]. Notably, the YW795SL mutant in LLP3 reproduced the phenotype of CT144, with efficient incorporation in permissive cells and poor incorporation in nonpermissive cells (23). This suggests that trafficking motifs in the N-terminal portion of LLP3 may be responsible for the cell type-dependent incorporation of Env.
We previously reported that expression of a C-terminal fragment of FIP1C (FIP1C560–649) retained or “trapped” Env in a perinuclear compartment, with a corresponding reduction in the incorporation of Env into particles (10). Trapping of Env by FIP1C560–649 was dependent on the presence of the CT and resulted in prominent Env colocalization with ERC markers such as Rab11a and Rab14 (10). This suggested to us that FIP1C560–649 colocalization could be used to map motifs in the CT that mediate ERC interactions and subsequent recycling events. We note that the failure of a CT mutant Env to be localized in the ERC as analyzed by this method could either be due to failure to reach the ERC or could reflect failure to be retained in this compartment. In the present study, we define specific residues within the Env CT that are required for trafficking to/retention in the ERC. Using CT truncation followed by site-directed mutagenesis, we found that residues adjacent to the LLP2-LLP3 junction are required for ERC retention of Env. Mutations in two tryptophan-based motifs in the N-terminal portion of LLP3 (WE790–791 and WW796-797) resulted in a significant loss of particle incorporation, and viruses bearing substitutions in these motifs replicated very poorly in T cell lines. Thus, the tryptophan motifs in the N-terminal portion of LLP3 mediate both ERC localization and particle incorporation, emphasizing the importance of host recycling pathways in determining particle incorporation of Env.
RESULTS
Mapping determinants in CT is required for ERC localization of Env
To define which region of the CT plays a role in ERC localization, we initially constructed a series of Env proteins in which the structural LLPs were deleted from C- to N-terminus, beginning with the most C-terminal (ΔCT33), then ΔCT71, and finally ΔCT104 (Fig. 1A, with the position of the stop codon shown in Fig. 1B). An additional construct, ΔCT82, extended the deletion into LLP2 with a stop codon following residue 774 (relative to the HXB2 reference strain). We then coexpressed each of the truncated Env proteins shown in Fig. 1 with FIP1C560–649 and assessed colocalization of Env with FIP1C560–649 as a measure of ERC localization. As described previously (10), wildtype (WT) Env strongly colocalized with FIP1C560–649 in the perinuclear ERC (Fig. 2A, top panel), while Env bearing a truncation of 144 residues of the CT did not (Fig. 2A, ΔCT144). Deletion of the C-terminal LLP1 alpha helix resulted in more Env localized outside of the ERC than WT, along with a partial reduction in colocalization (Fig. 2A, ΔCT33, with quantitation in Fig. 2B). CT truncation that resulted in the loss of two C-terminal LLPs (LLP3 and LLP1) resulted in a more severe loss of colocalization, suggesting an important role for determinants in LLP3 (Fig. 2A and B, ΔCT71). Complete loss of colocalization was observed when the truncation was performed within the midportion of LLP2, resulting in loss of the 82 residues following L774 (Fig. 2A and B, ΔCT82). A truncation that resulted in the loss of all three LLPs also showed complete loss of colocalization, similar to results seen with ΔCT82 and with ΔCT144 (Fig. 2A and B, ΔCT104). The sequential loss of ERC colocalization is depicted in Fig. 2B, illustrating that the loss of the C-terminal 82 residues of the CT was sufficient to completely prevent ERC localization. These CT truncation results support a model in which the LLPs play a role in Env trafficking to the ERC. The LLP2/LLP3 junction was selected for further studies, as complete loss of colocalization required both LLP3/LLP1 deletion and the C-terminal portion of LLP2 represented by ΔCT82.
In order to further evaluate the importance of this region in mediating ERC localization of Env, we next created an internal deletion of residues 786–801, representing the very N-terminal segment of LLP3 (Fig. 1B), while keeping LLP2 and LLP1 intact. Remarkably, this mutant was completely excluded from the ERC (Fig. 2A, with quantitation shown in Fig. 2B). We noted a subtle difference in subcellular distribution of Δ786–801 from that of ΔCT144, with Δ786–801 present in larger compartments outside of the ERC, consistent with defective Env sorting and failure to reach the ERC. The fact that this internal deletion at the N-terminus of LLP3 disrupted ERC localization and perturbed Env distribution reinforces the importance of this region in the intracellular trafficking of Env.
Cell type-specific differences in incorporation of Env with disruption of LLP3
We next examined the incorporation of truncated Env into released particles, testing the hypothesis that mutants that were unable to reach the ERC would be deficient in particle incorporation. To do so, we generated truncation mutants within the NL4-3 proviral expression plasmid by inserting stop codons at the specific locations shown in Fig. 1B. All Env deletion constructs in the proviral context resulted in the release of virus from transfected 293T or HeLa cells at a level comparable to WT as measured by p24 enzyme-linked immunosorbent assay (data not shown). Env incorporation was assessed by western blotting of viruses produced from transfected HeLa cells and from H9 cells infected with VSV-G pseudotyped viruses. Note that we chose these two cell types in order to contrast a semipermissive cell type (HeLa) with that of a nonpermissive cell type (H9). As expected, ΔCT144 Env was incorporated into particles produced from transfected HeLa cells, although to a lesser extent than WT (Fig. 3A and C). Deletion of all three LLPs (ΔCT104, Fig. 3A) allowed Env incorporation at levels slightly above that of ΔCT144 (Fig. 3C). Truncation of the CT prior to the C-terminal LLP1 domain (ΔCT33) reduced Env incorporation to levels similar to those of CT144. Surprisingly, deletion of LLP1 and LLP3 while maintaining all (ΔCT71) or just the N-terminal portion of LLP2 (ΔCT82) completely eliminated Env incorporation into particles produced from HeLa cells without disrupting cellular levels of Env (Fig. 3A and C). These results, showing a loss of Env incorporation for truncations in LLP2 and LLP3, but not for more drastic truncations (ΔCT144, ΔCT104) or less drastic mutations (ΔCT33), are reminiscent of findings previously observed by the Aiken laboratory (30). In contrast to HeLa cells, when these same CT-truncated viruses were produced from infected H9 cells, all truncations resulted in near-complete defects in Env incorporation (Fig. 3B). This suggests that cell type-specific differences in Env incorporation exist that can be mapped within the CT, and that the LLP2/3 junction may be key to understanding the differences seen in nonpermissive vs permissive cells.
The cell type-specific Env incorporation differences with CT truncation mutants described above were not completely explained by levels of cell surface Env. In HeLa cells, removal of LLP1 (ΔCT33) resulted in a reduction of cell surface Env down to 47% of WT, while ΔCT71 reduced cell surface Env to 63% of WT, and ΔCT82 dropped Env to 71% of WT (Fig. 3E and F). In contrast, ΔCT104 and ΔCT144 were significantly enriched on the cell surface relative to WT, with a 229% increase in mean fluorescence intensity (MFI) for ΔCT104 and a 231% increase in MFI for ΔCT144 (Fig. 3E and F). Findings in H9 cells were similar to those in HeLa, with diminished cell surface Env for ΔCT33, ΔCT71, and ΔCT82 (28%, 35%, and 63% of WT, respectively) and increased cell surface Env for ΔCT104 and CT144 (161% and 137%, respectively; Fig. 3G and H). Thus, truncations removing LLP1, LLP1, and LLP3, or part of LLP2 in conjunction with LLP3 and LLP1, reduced cell surface Env, while complete removal of all three LLPs or truncation of the C-terminal 144 residues led to significantly increased cell surface envelope levels in both cell types. One interpretation of these findings is that removal of CT motifs relevant to Env trafficking and particle incorporation reduces incorporation of Env in nonpermissive cells, as reflected in poor Env incorporation even in the presence of enhanced cell surface Env in the H9 T cell line. In HeLa cells, however, significant increases in cell surface levels resulting from LLP2/LLP3/LLP1 deletion or ΔCT144 are able to overcome this trafficking defect through another mechanism, such as passive incorporation when there are increased levels of Env at the PM.
Alanine scanning mutagenesis of the LLP2/3 junction
Results above with CT truncation constructs suggested that the LLP2/3 region is required for Env enrichment in the condensed ERC and also plays a role in regulating particle incorporation. We next sought to identify key residues or specific motifs that determine ERC localization and particle incorporation. We therefore performed alanine scanning mutagenesis within the C-terminus of LLP2 and the N-terminal portion of LLP3 (throughout the region spanning L774 to N809, depicted in Fig. 1C). Amino acids in this region of codon-optimized JRFL Env were mutated in pairs to alanines to ablate their functional groups, while existing alanine residues in this region were left unchanged. Each mutant was transfected into HeLa cells together with FIP1C560–649, and colocalization was measured as before. Representative images are shown in Fig. 4A. Quantitation of colocalization was performed from 20 images for each mutant, with the results shown in Fig. 4B. The majority of alanine substitution introduced into the LLP2/3 junction had no or minimal effects on colocalization with FIP1C560–649 (represented by KY794AA; Fig. 4A). However, five mutants demonstrated significantly reduced colocalization, as shown in Fig. 4B, with representative images in Fig. 4A. From these, we selected the three most N-terminal mutants for evaluation in the context of proviruses in order to further elucidate the role of the LLP2/LLP3 junction. These residues are depicted in Fig. 1D and E, derived from the published CT baseplate structure (19). These included a dileucine motif (LL784) at the C-terminus of LLP2, a highly conserved tryptophan glutamate dyad (WE790) motif at the N-terminus of LLP3, and a dual tryptophan (WW796) seven amino acids into LLP3 [overlapping with the previously described YW795 motif implicated in FIP1C-mediated Env trafficking (23)].
Effect of LLP2/3 mutations in the context of the NL4-3 virus
The three dual-residue motifs identified above were next mutated within the context of the NL4-3 provirus, individually and in combination. In order to maintain amino acid identity within the rev open reading frame, we were unable to employ alanine codons for two of these motifs but instead generated substitutions to residues other than alanine (LL784RR and WW796LS), while the WE790AA substitution was introduced as in the Env expression studies above. While assessing colocalization of NL4-3 Env mutants with the ERC, we observed that the condensed ERC generated upon GFP-FIP1C560–649 expression was frequently disrupted in transfected cells, resulting in a more diffuse cytoplasmic distribution of the GFP signal (compare Fig. 5A and B). This was true even in the absence of Env (Fig. 5B, NL ΔEnv, right images), suggesting that another viral factor was causing the loss of condensation in the recycling compartment. Quantification of the area of diffuse GFP-FIP1C560–649 signal from infected cells vs FIP1C560–649 alone demonstrated the degree to which recycling membranes are disrupted during proviral expression (Fig. 5C). Approximately 10% of infected cells displayed highly condensed FIP1C560–649 compartments (Fig. 5D), and we chose to assess Env colocalization with FIP1C560–649 only in those cells.
Individually, substitutions that had been found to be defective in ERC localization when expressed as Env alone had less of an effect on reducing ERC localization when expressed in intact viruses (Fig. 5E and G). To further examine the role of the residues surrounding the LLP2/LLP3 junction in Env incorporation, we generated combinations of two (LL784RR/WE790AA, LL784RR/WW796LS, and WE790AA/WW796LS) or all three (LL784RR/WE790AA/WW796LS) paired amino acid substitutions. LL784RR/WW796LS maintained ERC localization, which was not significantly different than the individual paired substitutions. Remarkably, however, WE790AA/WW796LS and LL784RR/WE790AA/WW796LS displayed significantly reduced ERC concentration as measured by colocalization with condensed FIP1C560–649 in 20 cells (Fig. 5F and G). Additionally, LL784RR/WE790AA appeared to be weakly reduced relative to WT (Fig. 5G). Thus, we conclude that the WE790AA/WW796LS mutant in the viral context reproduced the phenotype originally mapped by loss of ERC localization through truncation and deletion constructs, suggesting an important contribution for these tryptophan-based motifs within LLP3 in ERC localization.
Continuing the logic employed in the truncation studies above, we hypothesized that the dual tryptophan pair mutation that disrupted ERC localization (WE790AA/WW796LS) would result in diminished Env incorporation into particles. When particles were produced from HeLa cells, single motif substitutions LL784RR and WE790AA had modest effects on Env particle incorporation as measured by the gp41/p24 ratio, while WW796LS was reduced to 55% of WT (Fig. 6A and C). The dual-paired mutants LL784RR/WE790AA and LL784RR/WW796LS were incorporated to nearly the same extent as the WW796LS mutation (56% and 45% of WT, respectively). However, combining substitutions of both tryptophan-containing motifs (WE790AA/WW796LS) resulted in a much more robust reduction in Env incorporation at 32% of WT. The triple mutant, LL784RR/WE790AA/WW796LS, demonstrated reduced Env incorporation similar to WE790 AA/WW796LS (Fig. 6A and C), suggesting that the tryptophan motifs were the critical determinants for particle incorporation and not the dileucine motif. The level of Env particle incorporation for the dual tryptophan motif mutant and for the triple motif mutant was reduced more substantially when particles were harvested from infected H9 T cells (Fig. 6B and D). These results support the idea that mutations in LLP3 that disrupt ERC localization result in a corresponding reduction in particle incorporation of Env.
Disruption of CT motifs involved in recycling might be expected to reduce cell surface levels of Env. However, in transfected HeLa cells, a significant reduction was not observed, but instead there was a modest increase in cell surface Env for three mutants (LL784RR, WE790AA, and LL784RR/WE790AA; Fig. 6E and F). The dual tryptophan motif substitution WE790AA/WW796LS was reduced slightly, but this reduction did not reach statistical significance (Fig. 6F). In H9 cells, the trend was substantially different, as each of the panel of mutants except LL784RR was significantly reduced on the cell surface of infected cells. WE790AA/WW796LS and LL784RR/WE790AA/WW796LS showed the most robust reduction, with only 26% and 32% of WT cell surface Env, respectively (Fig. 6G and H). Thus, in H9 cells, a significant reduction in cell surface Env was observed for those mutants that failed to localize with the ERC, perhaps a reflection of diminished recycling to the PM.
We anticipated that the LLP2/3 junction mutants that incorporated Env poorly would demonstrate defects in particle infectivity and in multiple-round replication assays. For the individual mutations LL784RR and WE790AA and for the two dual motif mutants LL784RR/WE790AA and LL784RR/WW796LS, we observed a reduction in infectivity corresponding with the loss of incorporation described previously (Fig. 7A). In agreement with the Env incorporation studies above, we observed a more significant and robust reduction in infectivity for WE790AA/WW796LS and LL784RR/WE790AA/WW796LS viruses (Fig. 7A). We then examined the LLP2/3 mutants in multiple round/spreading infection assays in H9 cells. Viruses containing the single motif substitutions LL784RR, WE790AA, and WW796LS demonstrated significantly impaired replication (Fig. 7B). Notably, combining these substitutions in WE790AA/WW796LS and LL784RR/WE790AA/WW796LS resulted in a more severe defect in replication in H9 cells (Fig. 7C). LL784RR/WE790AA and LL784RR/WW796LS showed an intermediate degree of delay in replication as compared with the viruses containing substitutions in both tryptophan-based motifs. Together, these results implicate two tryptophan-based motifs located at the very N-terminus of LLP3, WW796–797 and WE790–791, in ERC localization, Env incorporation, and viral replication.
Tryptophan-based motif substitutions in LLP3 prevent the movement of FIP1C out of the ERC
FIP1C has been previously implicated as an ERC-enriched adaptor protein that plays a role in Env trafficking and particle incorporation (10, 11, 23). When Env is expressed, FIP1C redistributes from the ERC to more peripheral parts of the cell, including the PM, and this redistribution requires the CT. The YW795SL mutant in LLP3 was previously shown to be deficient in eliciting FIP1C redistribution (23). We expressed Env proteins with substitutions in the tryptophan-based motifs described above (WE790AA/WW796LS and LL784RR/WE790AA/WW796LS) together with FIP1C-GFP and assessed the subcellular localization of FIP1C. Note that the green signal here is full-length FIP1C-GFP, not the truncated FIP1C560–649 fragment used in earlier experiments. Figure 8A shows the typical redistribution of perinuclear FIP1C to the cellular periphery by WT Env (top panels). The double tryptophan mutant WE790AA/WW796LS failed to redistribute FIP1C-GFP, and similarly, the triple mutant LL784RR/WE790AA/WW796LS failed to redistribute FIP1C-GFP (Fig. 8A, middle two rows). These results were basically identical to those seen previously with YW795SL, which again in this experiment was defective for FIP1C-GFP redistribution from the ERC (Fig. 8A, bottom row). The number of cells showing redistribution, defined as a predominance of FIP1C-GFP present outside of the perinuclear region (as in Fig. 8A, top row), was scored by two independent observers with good agreement and showed significant differences when comparing mutant Env (perinuclear) with WT (redistributed peripherally) (Fig. 8B). We conclude that the motifs identified here that result in loss of Env incorporation demonstrate a FIP1C redistribution phenotype similar to that of YW795SL and therefore may be disrupting the same step in Env trafficking that is altered by this mutation.
DISCUSSION
The HIV-1 envelope glycoprotein takes an unusual path to reach the PM site of assembly. After delivery to the PM, Env trimers are rapidly endocytosed, entering the early/sorting endosome (5, 6, 31). From this location, membrane proteins can be sorted via rapid or slow recycling pathways back to the plasma membrane or can be retained in maturing endosomes that eventually fuse with the lysosome. An alternative pathway mediated by the retromer complex can direct retrograde transport of Env to the Golgi (13). The pathways taken by HIV-1 Env from the early/sorting endosome remain incompletely defined. We have described a prominent role for the ERC in mediating Env incorporation, a pathway that was elucidated through the study of the trafficking adaptor FIP1C (10, 11). These studies suggested a model in which directed recycling from the ERC, mediated by motifs within an intact CT and involving specific host adaptors, is required for Env incorporation into developing particles. An intriguing aspect of this line of investigation was the identification of a mutant in the Env CT that was deficient in Env incorporation and replication, YW795SL (23). This mutation within the proximal portion of LLP3 rendered the virus deficient in incorporation in nonpermissive cell types while not affecting incorporation in permissive cells. This suggested that this region of the CT is critical for cell type-specific particle incorporation, and that it may be involved in the recycling of Env to the PM site of assembly. Other studies have also pointed to the key role of the N-terminal portion of LLP3 in Env incorporation (21, 22). However, a model in which directed trafficking or co-targeting of Env to the particle assembly site is required for particle incorporation is one of several potential models for Env incorporation as proposed by the Freed laboratory (2). Another leading model to explain the requirement for the CT is the direct interaction model. A direct interaction between the CT and MA has been supported by several lines of evidence. Two biochemical studies have reported direct binding between MA and CT (32, 33). Suggestive evidence for direct Gag-Env CT interaction comes from the fact that maturation is required in order to “liberate” the CT from Gag and allow viral fusion, and that this constraint on fusion posed by the uncleaved Gag lattice can be relieved by truncation of the CT (34 – 38).
The goal of the present study was to identify specific motifs in the Env CT required for efficient recycling and particle incorporation, using ERC localization as the phenotype to identify recycling-competent Env. Using a truncated form of FIP1C as a probe for ERC localization, we found that truncation of the CT within LLP2, resulting in loss of the C-terminal portion of LLP2 and all of LLP3 and LLP1 (ΔCT82), resulted in complete loss of ERC localization. This truncation mutant links the findings of ERC localization with incorporation into particles, as the loss of trafficking to the ERC was associated with the loss of particle association, despite Env being present at the cell surface at levels comparable to WT. The importance of the LLP2/3 junction was further highlighted by findings with a small internal deletion spanning this junction (Δ786–801), a deletion that resulted in Env exclusion from the ERC. Alanine-scanning mutagenesis then identified leucine- and tryptophan-based motifs at the LLP2/LLP3 junction that were important for ERC localization when Env and FIP1C560–649 were coexpressed. Upon introduction into an intact provirus, the effects of single motif disruption were incomplete, while disruption of two tryptophan-based motifs, WE790–791 and WW796–797, resulted in a significant loss of Env incorporation, particle infectivity, and reduction in replication in multiple round replication assays. Together, these results strongly suggest a connection between CT-dependent Env localization in the ERC and incorporation into HIV-1 particles. We note that the observed loss of ERC localization with deletion or substitution mutants may be due to disruption of interactions with specific recycling factors or, alternatively, may represent the effect of interfering with other trafficking pathways that prevent delivery to the ERC.
This study corroborates the importance of the N-terminal segment of the LLP3 region to Env particle incorporation that has been described in a number of previous studies (20, 21, 32, 35). A novel aspect of this study is that it demonstrates that ERC localization as determined in HeLa cells and particle incorporation in nonpermissive cell lines such as H9 are linked. The finding that ERC trafficking correlates with particle incorporation provides more support for a model in which CT-dependent recycling of Env trimers directed by host cell-specific factors is required for particle incorporation. This would be most consistent with a co-targeting model of Env incorporation, in which Gag and Env are delivered to the site of particle assembly on the PM via different routes (2). Notably, the co-targeting/recycling model remains compatible with a requirement for CT-MA interactions, as Env delivery to the site of Gag particle assembly may be a prerequisite to direct interactions.
We noted here as others have that partial Env CT truncations in HeLa cells that preserved LLP2 (represented here by ΔCT71 and ΔCT82) inhibited Env incorporation into particles, while deletion of all or a portion of LLP2 allowed more efficient Env incorporation. A similar phenotype had previously been described by the Aiken laboratory with their truncation studies (30). This finding was unique to this semipermissive cell line, as incorporation of Env with all of the truncations studied here was significantly reduced in H9 cells. We propose that this can be explained by competing pathways of intracellular trafficking, with the N-terminal portion of LLP3 involved in Env recycling to the plasma membrane while LLP2 includes one of two motifs known to direct Env trafficking to the trans-Golgi network in a retromer-dependent manner (13). Thus, truncations that eliminate LLP3 while preserving LLP2 shunt Env away from assembly sites and into internal compartments, while truncations that remove all of LLP2 and LLP3 result in an increased quantity of Env on the plasma membrane, which may enhance Env incorporation through a passive incorporation mechanism (2). In nonpermissive cells such as H9, this passive or secondary incorporation mechanism is not present, so enhanced cell surface envelope concentration results in no increase in Env incorporation into particles. Although this interpretation is admittedly likely to be an oversimplification, it provides a working model that ties trafficking mediated by LLP2 or LLP3 to the observed differences in cell type-specific Env incorporation.
It will be important to further define the recycling function mediated by the identified tryptophan-based motifs within the N-terminal portion of LLP3. Note that the WW796 substitutions studied here include alteration of the same tryptophan residue identified in the YW795SL mutant as important for Env incorporation and replication in nonpermissive cell lines (23). Both of these studies identified this key portion of the CT through screening mutants using assays related to intracellular trafficking: the first through a loss of cytoplasmic relocalization of FIP1C by YW795SL Env (23) and the present study through a completely different screening strategy employing ERC colocalization of Env. It is not clear at this time if the tryptophan-based motifs contribute to Env trafficking through direct interactions with host cell trafficking molecules or through a more indirect role. However, a loss of redistribution of FIP1C from a predominantly perinuclear location was seen with these tryptophan mutants and with YW795SL, suggesting that the mechanism may be shared. We note that the significance of FIP1C as a trafficking factor for Env in some cell types has recently been questioned (39). These authors demonstrated that FIP1C depletion or knockout resulted in defects in Env incorporation in HeLa, SupT1, and H9 cells and a significant reduction in spreading HIV replication in H9 cells that could be overcome at high cell density. However, knockout on a population basis in activated CD4+ T cells did not show a defect in spreading infection at early time points, leading them to conclude that FIP1C is not required for HIV replication in primary T cells. These findings may mean that there is some redundancy in the trafficking adaptors involved in Env incorporation, and that FIP1C as a single factor cannot fully explain cell type-dependent incorporation of Env. We propose that, despite some limitations, the role of FIP1C in particle incorporation of Env provides an important window into the interactions of Env with host recycling pathways. Findings here linking ERC-deficient localization of Env mutants with a loss of particle incorporation add to the body of evidence that recycling pathways are essential for Env incorporation. Future studies will be required to fully elucidate the host recycling factors that are required for Env incorporation in nonpermissive cells such as primary T cells and macrophages.
MATERIALS AND METHODS
Cells and plasmids
HeLa cells were obtained from ATCC (CCL-2). 293T cells were obtained from ATCC (CRL-3216). TZM-bl cells were obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH (ARP-8129), contributed by Dr. John C. Kappes and Dr. Xiaoyun Wu. HeLa, 293T, and TZM-bl cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 IU penicillin, and 100 µg/mL streptomycin. H9 T-lymphoid cells were obtained from ATCC (HTB-176) and were grown in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% FBS, 2 mM L-glutamine, 100 IU penicillin, and 100 µg/mL streptomycin. Strain NL4-3 Infectious Molecular Clone (pNL4-3), ARP-2852, was obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Human Immunodeficiency Virus 1 (HIV-1), contributed by Dr. M. Martin. pNL4-3 CTΔ144 was provided by Eric Freed at the NCI Viral Replication and Dynamics Program, Frederick, MD. GFP-FIP1C, GFP-FIP1C560–649, and codon-optimized JR-FL Env expression plasmids have been described previously (10, 11).
Cloning of Env deletion and substitution mutants
PCR was performed on a Bio-Rad T100 Thermal Cycler with the primers outlined in Table S1 (supplemental materials). Amplified PCR products for truncation mutations in codon-optimized Env were digested and ligated between EcoRI and NotI sites in pcDNA5/TO (Addgene). Ligated plasmid DNA was then transformed into JM109-competent cells (Promega). Site-directed mutagenesis of codon-optimized Env was performed using Quikchange (Agilent Technologies, Santa Clara, CA, USA), followed by digestion with DpnI and transformation into JM109 cells. Truncation mutations in NL4-3 were created by subcloning the region of NL4-3 between EcoRI and XhoI into pBlueScript KS(−) (Addgene), followed by site-directed mutagenesis to introduce a stop codon to generate the desired truncation mutation, and then reinsertion into the NL4-3 backbone and transformation into Stbl4 electrocompetent cells (Thermo Fisher Scientific, Waltham, MA, USA). Point mutations were inserted into NL4-3 from ordered gene fragments containing the desired mutations amplified by the amplification primers listed in Table S1 and ligated between the NheI and XhoI regions of NL4-3, ligating these fragments into the NL4-3 backbone and transforming into Stbl4 cells.
Immunofluorescence microscopy
Cells were fixed for imaging with 4% paraformaldehyde in phosphate buffered saline (PBS) for 15 min, followed by three PBS washes. Permeabilization was performed using 0.2% Triton X-100 diluted in PBS for 5 min, followed by three washes with PBS. Cells were blocked using Dako protein block (Agilent Technologies) for 30 min, washed once with PBS, and then incubated with a primary antibody diluted in Dako antibody diluent (Agilent Technologies) for 1 h. Primary antibodies included 2G12 for Env and KC57 for Gag. Cells were washed thrice with PBS buffer containing 1% bovine serum albumin (BSA) and 0.05% IGEPAL CA-630 (Sigma Aldrich, St. Louis, MO, USA) and then stained with secondary antibodies diluted in Dako antibody diluent. The secondary antibody for Env was antihuman Alexa Fluor 647 (Thermo Fisher Scientific). Cells were then washed with PBS once, stained with DAPI at 5 µg/mL, and washed twice more with PBS. Cells were then imaged using a DeltaVision widefield deconvolution microscope (Leica Microsystems, Wetzlar, Germany).
Measurement of particle infectivity
Tzm-bl cells were seeded at a density of 1.5 × 104 cells per well of a 96-well plate and incubated overnight at 37°C. Viral supernatants were diluted 1:5 in quadruplicate in DMEM media containing 16 µg/mL diethylaminoethyl (DEAE)-dextran in the first well of a 96-well plate. Samples were serially diluted from 1:5 in column one to 1:48,828,125 in column 11. Diluted viral supernatants were then added to Tzm-bl cells and incubated at 37°C for 48 h. Following incubation, 100 μl of media was removed from the plate and incubated with 100 μl Britelite Plus reagent (PerkinElmer, Waltham, MA, USA) for 2 min, followed by mixing and transferring to a black 96-well assay plate. Samples were then analyzed using the Synergy Neo2 (BioTek Instruments, Winooski, VT, USA).
HIV spreading infection assay
Three million H9 cells were infected overnight with 150 ng of VSV-G pseudotyped NL4-3 virus bearing WT or mutant Env. These cells were washed the following day and resuspended in 1 mL of RPMI 1640 media supplemented with 10% FBS, 2 mM L-glutamine, 100 IU penicillin, and 100 µg/mL streptomycin. Every 2 to 3 days, 100 µL of media was removed to measure p24 production and replaced with 200 µL of fresh media. P24 in supernatants was quantified by an antigen-capture enzyme-linked immunosorbent assay (ELISA).
Western blotting for viral proteins
Viruses were pelleted through a 20% sucrose cushion and resuspended in radioimmunoprecipitation assay (RIPA) buffer, and cells were lysed with RIPA buffer. Both viral supernatants and cell lysates were normalized for p24 by ELISA prior to loading onto gels. Then, 4%–12% gradient Bis-Tris gels were purchased from Thermo Fisher Scientific or cast at the time of use from 10% polyacrylamide in 0.36 M Bis-Tris buffer pH 6.4. Env was detected with 2F5 human anti-gp41 (Polymun Scientific, Klosterneuburg, Austria) or 2G12 for gp120/gp160, both diluted 1:1,000 in Intercept blocking buffer (Licor Biosciences, Lincoln, NE, USA) with 0.15% Tween-20. Blots were normalized for p24 as measured by ELISA; Gag was blotted with mouse anti-p24 antibody CA183 and also diluted 1:1,000 in Intercept buffer with 0.15% Tween-20. Secondary staining was performed with Licor secondary antibodies diluted 1:5,000 in the same blocking buffer solution.
Flow cytometry
For cell surface staining, HeLa cells were plated at a density of 400,000 per well of a six-well plate and transfected with 400 ng of mutant Env. Then, 24 h post transfection, cells were stained with zombie violet dye (BioLegend/Perkin Elmer) diluted 1:500 in PBS and then fixed with 4% paraformaldehyde. Cells were washed twice with PBS and then blocked with Dako blocking reagent, followed by staining on the cell surface with 2G12 anti-gp120 directly conjugated to allophycocyanin (APC) (Abcam, Cambridge, UK; ab201807) diluted 1:100 in Dako antibody diluent for 2 h. 2G12 was washed with PBS twice, followed by permeabilization with 0.2% Triton X-100 and staining for intracellular Gag with KC57-FITC (Beckman Coulter, Pasadena, CA, USA; 6604665) diluted 1:100 in Dako antibody diluent. Cells were washed with PBS and resuspended in MACS buffer (Miltenyi Biotec, North Rhine-Westphalia, Germany), followed by analysis using BD FACS Canto II. Alternatively, 5 million H9 cells were infected overnight with an appropriate viral mutant with 1 μg of p24 in 1 mL to ensure a high degree of infection. H9 cells were washed once with PBS the next day and incubated with 2 mL of RPMI for an additional 24 h. On the next day, cells were processed as described previously.
ACKNOWLEDGMENTS
This work was supported by R01 AI150486. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. Flow cytometry was performed using the Cincinnati Children’s Hospital Medical Center (CCHMC) Flow Cytometry Core. DNA sequencing was performed at the DNA Sequencing Core at CCHMC.
Contributor Information
Paul Spearman, Email: paul.spearman@cchmc.org.
Frank Kirchhoff, Ulm University Medical Center, Ulm, Baden-Württemberg, Germany .
SUPPLEMENTAL MATERIAL
The following material is available online at https://doi.org/10.1128/jvi.00631-23.
ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.
REFERENCES
- 1. Bernstein HB, Tucker SP, Hunter E, Schutzbach JS, Compans RW. 1994. Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J Virol 68:463–468. doi: 10.1128/JVI.68.1.463-468.1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Checkley MA, Luttge BG, Freed EO. 2011. HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol 410:582–608. doi: 10.1016/j.jmb.2011.04.042 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Willey RL, Bonifacino JS, Potts BJ, Martin MA, Klausner RD. 1988. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein Gp160. Proc Natl Acad Sci U S A 85:9580–9584. doi: 10.1073/pnas.85.24.9580 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk HD, Garten W. 1992. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein Gp160. Nature 360:358–361. doi: 10.1038/360358a0 [DOI] [PubMed] [Google Scholar]
- 5. Rowell JF, Stanhope PE, Siliciano RF. 1995. Endocytosis of endogenously synthesized HIV-1 envelope protein. mechanism and role in processing for association with class II MHC. J Immunol 155:473–488. [PubMed] [Google Scholar]
- 6. Ohno H, Aguilar RC, Fournier M-C, Hennecke S, Cosson P, Bonifacino JS. 1997. Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family. Virology 238:305–315. doi: 10.1006/viro.1997.8839 [DOI] [PubMed] [Google Scholar]
- 7. Boge M, Wyss S, Bonifacino JS, Thali M. 1998. A membrane-proximal tyrosine-based signal mediates Internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor. J Biol Chem 273:15773–15778. doi: 10.1074/jbc.273.25.15773 [DOI] [PubMed] [Google Scholar]
- 8. Wyss S, Berlioz-Torrent C, Boge M, Blot G, Höning S, Benarous R, Thali M. 2001. The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 Clathrin Adaptor. J Virol 75:2982–2992. doi: 10.1128/JVI.75.6.2982-2992.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Byland R, Vance PJ, Hoxie JA, Marsh M. 2007. A conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope protein. Mol Biol Cell 18:414–425. doi: 10.1091/mbc.e06-06-0535 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Kirschman J, Qi M, Ding L, Hammonds J, Dienger-Stambaugh K, Wang J-J, Lapierre LA, Goldenring JR, Spearman P, Kirchhoff F. 2018. HIV-1 envelope glycoprotein trafficking through the endosomal recycling compartment is required for particle incorporation. J Virol 92:e01893–17. doi: 10.1128/JVI.01893-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Qi M, Williams JA, Chu H, Chen X, Wang J-J, Ding L, Akhirome E, Wen X, Lapierre LA, Goldenring JR, Spearman P. 2013. Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex. PLOS Pathog 9:e1003278. doi: 10.1371/journal.ppat.1003278 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Hoffman HK, Aguilar RS, Clark AR, Groves NS, Pezeshkian N, Bruns MM, van Engelenburg SB. 2022. Endocytosed HIV-1 envelope glycoprotein traffics to Rab14(+) late endosomes and lysosomes to regulate surface levels in T-cell lines. J Virol 96:e0076722. doi: 10.1128/jvi.00767-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Groppelli E, Len AC, Granger LA, Jolly C. 2014. Retromer regulates HIV-1 envelope glycoprotein trafficking and incorporation into virions. PLoS Pathog. 10:e1004518. doi: 10.1371/journal.ppat.1004518 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Rowell JF, Ruff AL, Guarnieri FG, Staveley-O’Carroll K, Lin X, Tang J, August JT, Siliciano RF. 1995. Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells. J Immunol 155:1818–1828. [PubMed] [Google Scholar]
- 15. Weaver N, Hammonds J, Ding L, Lerner G, Dienger-Stambaugh K, Spearman P. 2023. KIF16B mediates anterograde transport and modulates lysosomal degradation of the HIV-1 envelope glycoprotein. J Virol 97:e0025523. doi: 10.1128/jvi.00255-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Hunter E, Swanstrom R. 1990. Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol 157:187–253. doi: 10.1007/978-3-642-75218-6_7 [DOI] [PubMed] [Google Scholar]
- 17. Murphy RE, Samal AB, Vlach J, Saad JS. 2017. Solution structure and membrane interaction of the cytoplasmic tail of HIV-1 gp41 protein. Structure 25:1708–1718. doi: 10.1016/j.str.2017.09.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Piai A, Fu Q, Cai Y, Ghantous F, Xiao T, Shaik MM, Peng H, Rits-Volloch S, Chen W, Seaman MS, Chen B, Chou JJ. 2020. Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein. Nat Commun 11:2317. doi: 10.1038/s41467-020-16165-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Piai A, Fu Q, Sharp AK, Bighi B, Brown AM, Chou JJ. 2021. NMR model of the entire membrane-interacting region of the HIV-1 fusion protein and its perturbation of membrane morphology. J Am Chem Soc 143:6609–6615. doi: 10.1021/jacs.1c01762 [DOI] [PubMed] [Google Scholar]
- 20. Bültmann A, Muranyi W, Seed B, Haas J. 2001. Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression. J Virol 75:5263–5276. doi: 10.1128/JVI.75.11.5263-5276.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Murakami T, Freed EO. 2000. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and Α-Helix 2 of the gp41 cytoplasmic tail. J Virol 74:3548–3554. doi: 10.1128/jvi.74.8.3548-3554.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Bhakta SJ, Shang L, Prince JL, Claiborne DT, Hunter E. 2011. Mutagenesis of tyrosine and di-leucine motifs in the HIV-1 envelope cytoplasmic domain results in a loss of Env-mediated fusion and infectivity. Retrovirology 8:37. doi: 10.1186/1742-4690-8-37 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Qi M, Chu H, Chen X, Choi J, Wen X, Hammonds J, Ding L, Hunter E, Spearman P. 2015. A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type– and Rab11-FIP1C–dependent incorporation into virions. Proc Natl Acad Sci U S A 112:7575–7580. doi: 10.1073/pnas.1504174112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Blot G, Janvier K, Le Panse S, Benarous R, Berlioz-Torrent C. 2003. Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for Env incorporation into virions and infectivity. J Virol 77:6931–6945. doi: 10.1128/jvi.77.12.6931-6945.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Lambelé M, Labrosse B, Roch E, Moreau A, Verrier B, Barin F, Roingeard P, Mammano F, Brand D. 2007. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly. J Virol 81:125–140. doi: 10.1128/JVI.01659-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Murakami T, Freed EO. 2000. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc Natl Acad Sci U S A 97:343–348. doi: 10.1073/pnas.97.1.343 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Yu X, Yuan X, McLane MF, Lee TH, Essex M. 1993. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature Virions. J Virol 67:213–221. doi: 10.1128/JVI.67.1.213-221.1993 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Akari H, Fukumori T, Adachi A. 2000. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions. J Virol 74:4891–4893. doi: 10.1128/jvi.74.10.4891-4893.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Anokhin B, Spearman P. 2022. Viral and host factors regulating HIV-1 envelope protein trafficking and particle incorporation. Viruses 14:1729. doi: 10.3390/v14081729 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Jiang J, Aiken C. 2007. Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail. J Virol 81:9999–10008. doi: 10.1128/JVI.00592-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Egan MA, Carruth LM, Rowell JF, Yu X, Siliciano RF. 1996. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. J Virol 70:6547–6556. doi: 10.1128/JVI.70.10.6547-6556.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Alfadhli A, Staubus AO, Tedbury PR, Novikova M, Freed EO, Barklis E. 2019. Analysis of HIV-1 matrix-envelope cytoplasmic tail interactions. J Virol 93:e01079-19. doi: 10.1128/JVI.01079-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Cosson P. 1996. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J 15:5783–5788. [PMC free article] [PubMed] [Google Scholar]
- 34. Jiang J, Aiken C. 2006. Maturation of the viral core enhances the fusion of HIV-1 particles with primary human T cells and monocyte-derived Macrophages. Virology 346:460–468. doi: 10.1016/j.virol.2005.11.008 [DOI] [PubMed] [Google Scholar]
- 35. Jiang J, Aiken C. 2007. Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail. J Virol 81:9999–10008. doi: 10.1128/JVI.00592-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Murakami T, Ablan S, Freed EO, Tanaka Y. 2004. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. J Virol 78:1026–1031. doi: 10.1128/jvi.78.2.1026-1031.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Wyma DJ, Jiang J, Shi J, Zhou J, Lineberger JE, Miller MD, Aiken C. 2004. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J Virol 78:3429–3435. doi: 10.1128/jvi.78.7.3429-3435.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Wyma DJ, Kotov A, Aiken C. 2000. Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J Virol 74:9381–9387. doi: 10.1128/jvi.74.20.9381-9387.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Fernandez-de Céspedes MV, Hoffman HK, Carter H, Simons LM, Naing L, Ablan SD, Scheiblin DA, Hultquist JF, van Engelenburg SB, Freed EO. 2022. Rab11-FIP1C is dispensable for HIV-1 replication in primary CD4(+) T cells, but its role is cell type dependent in immortalized human T-cell lines. J Virol 96:e0087622. doi: 10.1128/jvi.00876-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.